Operative management in patients with upper tract urothelial carcinoma in Iceland: a population-based study

Scand J Urol. 2021 Jun;55(3):197-202. doi: 10.1080/21681805.2021.1916073. Epub 2021 Apr 29.

Abstract

Objective: Radical nephroureterectomy is the standard treatment of organ-confined upper tract urothelial carcinoma (UTUC). The objective of this study was to investigate survival and bladder recurrence rate in Icelandic patients with UTUC who underwent radical nephroureterctomy (RNU) or other procedures with curative intent.

Material and methods: All patients who were diagnosed with UTUC in Iceland from 2003 to 2016 and treated with curative intent were included in the study. Information on patients was obtained retrospectively from patients' medical records and from the Icelandic Cause of Death Registry.

Results: Overall 63 patients underwent a procedure for UTUC with curative intent in Iceland during the study period. The median age was 71 years and the majority were male (65%). In 50 patients (79%), the tumor was a primary UTUC. The most common procedure was RNU (78%) and eight patients (13%) underwent a kidney-sparing procedure. No patient died within 90 d of surgery. Twenty-eight patients (44%) had pathological stage T2 or higher, whereas 35 patients (56%) had pathological stage T1 or lower. The median follow-up time was 98.8 months . During the follow-up time 25 patients (40%) were diagnosed with recurrence in the bladder. Five-year cancer-specific survival (CSS) was 67%.

Conclusions: This population-based study shows that the oncologic outcome in Icelandic patients with UTUC is similar to what has been reported in other countries. Bladder recurrence rate is high and can hopefully be reduced by improvements in surgical and intravesical instillation treatment. Possibly more kidney-sparing surgeries could have been done during the study period; however, careful selection for those procedures is mandatory.

Keywords: Upper tract urothelial carcinoma; bladder recurrence; nephroureterectomy; survival.

MeSH terms

  • Carcinoma, Transitional Cell* / surgery
  • Female
  • Humans
  • Iceland / epidemiology
  • Male
  • Neoplasm Recurrence, Local / epidemiology
  • Retrospective Studies
  • Treatment Outcome
  • Ureteral Neoplasms* / surgery
  • Urinary Bladder Neoplasms*